DexCom Inc

DXCM: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
G$xLOCK|b!$nLOCK|$hhkkMz

DexCom Earnings: Another Solid Quarter Highlights Operational Improvements in 2026

DexCom's second-quarter results included solid 11% year-over-year growth in US revenue, while international sales rose more strongly at 16% in constant currency.

Sponsor Center